论文部分内容阅读
目的:回顾性地分析介入治疗后生存两年以上的54例肝癌病人,旨在探研影响介入治疗后患者长期生存率的相关因素.资料和方法:共54例,男、女各47、7例,年龄24～69岁,平均50岁,52例原发性肝癌,2例转移性肝癌.分析肝癌的类型、部位、大小、血供性、肝脏的 Child 氏分级、治疗方式及治疗次数等.结果:肿块为单结节、多结节和巨块型者各3、5、和46例.肿瘤大小情况:小于10cm 者28例,大于10cm 而小于15cm 者18例,大于15cm 而小于20cm 者6例,大于20cm 者2例.肿瘤血供呈富血性、中等富血及少血性者分别为39、12、1例.Child 氏分级 A、B、C 级分别为48、5、1例.治疗方式:①灌注加栓塞者48例;②灌注加单纯碘油栓塞3例,③灌注并内膜下栓塞者2例;④单纯灌注者1例.结论:肝癌病人介入治疗后的长期疗效与下列因素呈正相关:①肿瘤呈膨胀性生长,肿块<10～15cm;②富血性;⑧有包膜;④远离侧支循环丰富区域;⑤基础肝脏功能;⑨末梢性栓塞;⑦栓塞之永久性和⑧综合施治等.
OBJECTIVE: To retrospectively analyze 54 patients with liver cancer who survived more than two years after interventional therapy, in order to explore the relevant factors affecting the long-term survival rate of patients after interventional therapy. Data and Methods: A total of 54 patients, male and female, 47, 7 Cases, aged 24-69 years, mean 50 years old, 52 cases of primary liver cancer, 2 cases of metastatic liver cancer. Analysis of liver cancer type, location, size, blood supply, Child’s grade of liver, treatment methods and treatment times, etc. Results: The masses were single nodules, multiple nodules, and massive masses in 3, 5, and 46 cases. Tumor size: 28 cases less than 10cm, 18 cases greater than 10cm and less than 15cm, greater than 15cm and less than 20cm Among 6 cases, 2 cases were larger than 20cm. The blood supply of tumors was rich in blood, moderately rich in blood and less bloody. 39, 12 and 1 cases respectively. Child’s grades A, B and C were 48, 5 and 1 cases respectively. Treatment: 1 infusion and embolism in 48 cases; 2 infusion plus lipiodol embolization in 3 cases, 3 infusion and subintimal embolization in 2 cases; 4 infusion in 1 case. Conclusion: Long-term efficacy of interventional therapy in patients with liver cancer Positive correlation with the following factors: 1 The tumor showed expansive growth, mass <10 ~ 15cm; 2 rich in blood; 8 has an envelope; 4 away from the side Circulation rich region; ⑤ basis liver function; ⑨ distal embolization; permanent ⑦ ⑧ integrated embolism and differentiation and so on.